E. Schneider et al., New approaches to antiarrhythmic therapy - Emerging therapeutic applications of the cell biology of cardiac arrhythmias, EUR HEART J, 22(23), 2001, pp. 2148-2163
Cardiac arrhythmias complicate many diseases affecting the heart and the ci
rculation. and incorporate a multiplicity of underlying mechanisms. The evo
lution of scientific knowledge has made the complex changes produced by car
diovascular disease sufficiently understood at the organ, cellular. and mol
ecular levels such that there is a diversity of therapeutic targets for pha
rmacological therapy and/or prevention. Moreover, the approach of rational
drug design, in mechanism- and disease-specific fashion. facilitates target
ing of therapy via molecular, structural and translational biology. Additio
nal approaches, employing similar drug-design strategies but based on gene
therapy and transcriptional and translational modification are on the horiz
on. Hence, there is reason to be optimistic regarding the design, testing a
nd clinical availability of novel antiarrhythmic therapies. (C) 2001 The Eu
ropean Society of Cardiology.